On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

Ending the epidemic must include widespread, easy access to testing and prevention tools like PrEP (pre-exposure prophylaxis), say HIV experts. And those who are infected must be treated in order ...

The FDA approved Gilead’s landmark long-acting HIV treatment lenacapavir Wednesday afternoon. The drug will be marketed under ...

Jess Thomson is a Newsweek Science Reporter based in London UK. Her focus is reporting on science, technology and healthcare. She has covered weird animal behavior, space news and the impacts of ...

The bill, S.B. 339, authorizes pharmacists to furnish preexposure prophylaxis, commonly called PrEP, a drug that helps prevent HIV infection prior to exposure, as well as postexposure prophylaxis ...